Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | TAF1 | P21675 | 1/20 | 0.31 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.31 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.31 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.31 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL686703 | 0.73 | CYP2A6 (0.40) | PRKCICYP2A6PIK3CBMAPTKDM4E | |
| SCHEMBL443607 | 0.73 | PRKCI (0.44) | PRKCICYP2A6PIK3CBMAPTKDM4E | |
| SCHEMBL3483020 | 0.70 | PIK3CB (0.42) | PRKCICYP2A6PIK3CBMAPTKDM4E | |
| SCHEMBL1101086 | 0.70 | PRKCI (0.46) | PRKCICYP2A6PIK3CBMAPTKDM4E | |
| SCHEMBL3482881 | 0.70 | PIK3CB (0.46) | PRKCICYP2A6PIK3CBMAPTKDM4E | |
| SCHEMBL18683804 | 0.69 | PRKCI (0.60) | PRKCICYP2A6PIK3CBMAPTKDM4E | |
| SCHEMBL18230259 | 0.69 | PRKCI (0.44) | PRKCICYP2A6PIK3CBMAPTNQO2 | |
| SCHEMBL23331478 | 0.68 | — | — | |
| SCHEMBL29812 | 0.65 | CDK4 (0.56) | PRKCICYP2A6MAPTKDM4EALDH1A1 | |
| Bromide SCHEMBL31591097 | 0.63 | CDK4 (0.54) | PRKCICYP2A6MAPTKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2363 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543679-B1 | METHOD FOR ANALYZING DIFFUSION COEFFICIENT OF SOLVENT MOLECULES IN POLYMER MATERIAL | LG CHEMICAL LTD (KR) | 2025-10-01 | — | — | EP | claimed |
| EP-4612134-A1 | DIARYL DIAZOLE AND DIARYL TRIAZOLE DERIVATIVES FOR USE IN TREATING A DISEASE ASSOCIATED WITH KCNK13 ACTIVITY | Cerevance, Inc. (US) | 2025-09-10 | — | — | EP | claimed |
| CN-116554145-B | Aralkyl-4- (1H) indolylpiperazine derivative, preparation method and application thereof | 江苏恩华药业股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-115368351-B | Preparation method and application of polysubstituted oxazole compound | 广东工业大学 | 2025-03-25 | — | — | CN | claimed |
| CN-118271331-A | Gelsemin derivatives, synthesis method and application thereof in inhibiting tumor cell proliferation | 赣江中药创新中心 | 2024-07-02 | — | — | CN | claimed |
| CN-114805304-B | 4-Methoxyphenyl-1, 3-diamine derivative containing 1-methyl-1H-indole structure and application thereof | 辽宁大学 | 2024-05-31 | — | — | CN | claimed |
| WO-2024095005-A1 | DIARYL DIAZOLE AND DIARYL TRIAZOLE DERIVATIVES FOR USE IN TREATING A DISEASE ASSOCIATED WITH KCNK13 ACTIVITY | Cerevance, Inc. (US) | 2024-05-10 | — | — | WO | claimed |
| US-20240150318-A1 | PROTEASE INHIBITORS FOR TREATMENT OF CORONAVIRUS INFECTIONS | THE SCRIPPS RESEARCH INSTITUTE | 2024-05-09 | — | — | US | claimed |
| EP-4352040-A1 | PROTEASE INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS | The Scripps Research Institute (US) | 2024-04-17 | — | — | EP | claimed |
| CN-117794896-A | Protease inhibitors for the treatment of coronavirus infections | 斯克里普斯研究学院 | 2024-03-29 | — | — | CN | claimed |
| US-20140294805-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO EARLY DISCOVERY, INC. | 2014-10-02 | — | — | US | claimed |
| US-20140275057-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | Valo Health, LLC | 2014-09-18 | — | — | US | claimed |
| US-20140221351-A1 | NOVEL 1,2- BIS-SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2014-08-07 | — | — | US | claimed |
| US-20140051682-A1 | NOVEL 1,2- BIS-SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2014-02-20 | — | — | US | claimed |
| US-20120157444-A1 | NOVEL 1,2- BIS-SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | ALLERGAN, INC. (US) | 2012-06-21 | — | — | US | claimed |
| US-20100093744-A1 | THIOGLUCOSE SPIROKETAL DERIVATIVE AND USE THEREOF AS THERAPEUTIC AGENT FOR DIABETES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-04-15 | — | — | US | claimed |
| US-7652052-B2 | Process for producing ramosetron or its salt | ASTELLAS PHARMA INC. (JP) | 2010-01-26 | — | — | US | claimed |
| EP-2072522-A1 | THIOGLUCOSE SPIROKETAL DERIVATIVE AND USE THEREOF AS THERAPEUTIC AGENT FOR DIABETES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2009-06-24 | — | — | EP | claimed |
| US-20090069570-A1 | Novel Process for Producing Ramosetron or Its Salt | ASTELLAS PHARMA INC. (JP) | 2009-03-12 | — | — | US | claimed |
| EP-1870408-A1 | NOVEL PROCESS FOR PRODUCING RAMOSETRON OR ITS SALT | Astellas Pharma Inc. (JP) | 2007-12-26 | — | — | EP | claimed |